Results 41 to 50 of about 1,585 (132)

Biopolymeric Delivery Systems Enriched with Melaleuca alternifolia, Mentha piperita, and Polyhydroxy Acids for Acne Management: A Narrative Review

Cosmetics
Acne vulgaris is a prevalent inflammatory disorder of the pilosebaceous unit involving follicular hyperkeratinization, altered sebum production, Cutibacterium acnes proliferation, microbiome imbalance, and immune activation.
Mireya Suárez-Pérez, Octavio Dublán-García, Ana Gabriela Morachis-Valdez, Karinne Saucedo-Vence, Manuel Reinhart Kirchmayr, Francisco Antonio López-Medina, Guadalupe López-García, Ángel Santillán-Álvarez, Gerardo Heredia-García, Daniel Díaz-Bandera, Roxana Valdés-Ramos   +10 more
doaj   +1 more source

KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis – Results from a three‐armed RCT

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1050-1058, June 2026.
In this RCT, KOH 5% demonstrated superior clinical success to diclofenac 3% and placebo at the end of treatment in patients with mild‐to‐moderate actinic keratosis and comparable long‐term efficacy to diclofenac. Its fast onset of efficacy and favourable tolerability make KOH a valuable treatment option in early‐stage actinic keratosis treatment ...
U. Reinhold, N. Leitz, R. Dominicus, E. L. Szabó, T. Dirschka, G. Popp, T. C. Fischer, N. Adamini, R. Ostendorf, M. Asefi, H. Durani, T. Hölting, U. Amann, F. Kreuziger, T. Assmann, H. Brüning, L. Freitag, K. Hoffmann, R. Gedschold   +18 more
wiley   +1 more source

Post‐Inflammatory Hyperpigmentation: Molecular Mechanisms and Advances in Dermocosmetic Management

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Post‐inflammatory hyperpigmentation (PIH) is a condition that causes skin pigmentation after acute or chronic inflammation. It affects people with darker skin tones more than others, especially Asians (Fitzpatrick types III–VI), and can last for months or even years, making life much less enjoyable.
Rui Li, Baiyu Li, Qilin Zhang, Chunyu Zhao, Caixia Ye, Yang Chen, Claire Huguet, Wei Xiong, Valentine Beguin, Delphine Kerob, Yijie Zheng   +10 more
wiley   +1 more source

An Overview of the Diagnosis and Management of Seborrheic Dermatitis

Clinical, Cosmetic and Investigational Dermatology, 2022
Federica Dall’Oglio, Maria Rita Nasca, Carlo Gerbino, Giuseppe Micali Dermatology Clinic, University of Catania, Catania, ItalyCorrespondence: Giuseppe Micali, Dermatology Clinic, University of Catania, Via S.
Dall'Oglio F, Nasca MR, Gerbino C, Micali G   +3 more
doaj  

Formulation of Erytromycine and Tretinoin in a Topical Gel Base [PDF]

Journal of Kerman University of Medical Sciences, 2004
Acne vulgaris is a chronic and prevalent usually self-limited disorder. Topical medication is the main route for acne therapy. In this disorder the most widely used topical preparations are antibiotics such as Erythromycin and keratolytic agents such as ...
P Khazaeli, M Ansari, S Saryazdi, B Amin
doaj  

Herbal Therapy for the Treatment of Seborrhea Dermatitis

Clinical, Cosmetic and Investigational Dermatology, 2022
Resmi Mustarichie,1 Tina Rostinawati,2 Dian Ayu Eka Pitaloka,2 Nyi Mekar Saptarini,1 Yoppi Iskandar3 1Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia; 2Department of ...
Mustarichie R, Rostinawati T, Pitaloka DAE, Saptarini NM, Iskandar Y   +4 more
doaj  

Empowering Patient Self-care in Plantar Hyperkeratotic/Palmoplantar Keratodermas Eczema: A Case Report

Dubai Medical Journal
Introduction: Palmoplantar keratodermas (PPKs) include a range of inherited or acquired skin disorders characterized by thickening of the skin on the soles.
B. Parveen, Mathiyazhagan Narayanan, V. Rajinikanth   +2 more
doaj   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 887-899, May 2026.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Efficacy and Tolerability of a Triple Acid‐Containing Serum Combined With 0.1% Adapalene in Mild‐to‐Moderate Acne Vulgaris: A Randomized, Open‐Label Controlled Trial

Journal of Cosmetic Dermatology, Volume 25, Issue 5, May 2026.
ABSTRACT Background Although topical retinoids are first‐line therapy for mild‐to‐moderate acne, treatment‐related irritation often limits adherence to long‐term therapy. However, dermocosmetic adjuncts may improve treatment outcomes and tolerability.
Jing LYu, Jiajia Li, Yang Jiang, Sha Wang, Qingchun Diao   +4 more
wiley   +1 more source

Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure

British Journal of Clinical Pharmacology, Volume 92, Issue 4, Page 1256-1260, April 2026.
Abstract Congenital ichthyoses (CI) are rare, inherited skin disorders characterized by hyperkeratosis, scaling and fissuring that significantly impair patients' quality of life. Treatment options are limited, with systemic retinoids reserved for severe cases owing to their adverse effect profile.
Holm Schneider, Christopher G. Bunick, Kathrin Hillmann, Thy N. Huynh, Steven Kempers, Nicolai Peschel, Ulrike Blume‐Peytavi, Joyce M. C. Teng, Alan M. Mendelsohn, John Stinson, Lara Wine Lee   +10 more
wiley   +1 more source